Clinical Laboratory
COVID-19/Flu A&B/RSV Combo Antigen Rapid Test IRCF-MC84
RightSign · IRCF-MC84
Article No. AK-CL-172Product details
- Article number
- AK-CL-172
- Category
- Clinical Laboratory
- Brand
- RightSign
- Model
- IRCF-MC84
Description
The COVID-19/Flu A&B/RSV Combo Antigen Rapid Test by Hangzhou Biotest Biotech is a professional in vitro diagnostic test for the simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and RSV. The test is available in two variants – for nasal swabs and nasopharyngeal swabs – and enables rapid and differentiated diagnosis of acute respiratory infections. Thanks to the qualitative chromatographic immunoassay (lateral flow method), the test delivers reliable results after approximately 10 minutes. This allows healthcare professionals to identify sources of infection early and take targeted diagnostic or therapeutic action. Qualitative combo rapid test for the simultaneous detection of SARS-CoV-2, Influenza A/B, and RSV antigens Disposal: Dispose of test cassette after use according to local regulations, wear gloves and observe hygiene measures
Request a quotation
Equipment standard by AKLION — configuration, accessories and lead time are confirmed on the quotation.
Technical specifications
- Brand
- RightSign
- Model
- IRCF-MC84
- Product type
- Covid 19 Rapid Tests
- Material
- Plastic test cassette with integrated antibodies
- Swab variants
- Available as nasal swab or nasopharyngeal swab
- Package sizes
- 25 test cassettes per pack
- Test result
- Qualitative, visually readable in approx. 10 minutes
- Sensitivity
- Nasal swab 91-95%, Specificity 98-99%
- Storage
- 2–30 °C
- Shelf life
- 24 months
- Certification
- CE-certified according to Directive 98/79/EC (IVDD)
- Use
- For professional use only, not a lay test
- Test principle
- Qualitative lateral flow immunoassay (chromatographic rapid test)
- Detection
- SARS-CoV-2 (N-protein), Influenza A & B (nucleoproteins), RSV (respiratory syncytial virus)
- Sample type
- Nasal swab or nasopharyngeal swab